1. 1164PEfficacy of racotumomab or nimotuzumab vs docetaxel as second-line therapy for advanced non-small cell lung cancer patients. (23rd October 2018) Authors: Hernandez, M; Neninger, E; Santiesteban, E; Camacho, K; Hernandez, N; Amador, R; Acosta, S; Gonzalez, Y; Jimenez, Y; Corella, M; Ortiz, R A; Bello, L; Calana, A; Pichs, G; Cala, M; Flores, Y; Viada, C; Robaina, M; Crombet, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗